Alain Schaffter
Fortune : 308 639 $ au 31/05/2026
Fortune : 308 639 $ au 31/05/2026
M. Alain Schaffter est directeur financier de Bachem Holding AG et directeur financier de Solvias AG.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 3 138 ( 0 % ) | 308 639 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BACHEM HOLDING AG | Directeur Financier/CFO | 01/02/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| SPEXIS AG | Directeur Financier/CFO | - |
PricewaterhouseCoopers AG (Zurich)
PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services Provides auditing, accounting, tax, payroll and cybersecurity, cloud transformation & financial consulting services | Comptroller/Controller/Auditor | - |
| ACINO HOLDING AG | Directeur Financier/CFO | - |
Solvias AG
Solvias AG BiotechnologyHealth Technology Engages in medical research, development and manufacturing company | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bachem Holding AG
Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Spexis Ltd.
Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
PricewaterhouseCoopers AG (Zurich)
PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services Provides auditing, accounting, tax, payroll and cybersecurity, cloud transformation & financial consulting services | Commercial Services |
Solvias AG
Solvias AG BiotechnologyHealth Technology Engages in medical research, development and manufacturing company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national